NIH #R01CA294638
Assessment of Immune Responses to Neoantigen Vaccination in Lynch Syndrome
Active
- Amount
- $600K–$700K
- Period
- 2026-07-01 → 2031-06-30
- PIs
- 2
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Alexandre Reuben
Full Professor(heuristic)
Cancer Immunotherapy and Biomarkers · Oncology
Compare more Oncology professors.
h-index56
i10-index106
Publications431
Citations25,363
Grants
2 total · 1 active
NIH #R21CA283852
Unbiased electrothermal flow-enhanced identification of antigen-specific T cells in lung cancer
- Amount
- $400K–$500K
- Period
- 2023-09-19 → 2026-08-31
- PIs
- 2
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New preprint: TCR-FramePose: a local-frame representation for decomposing global docking and CDR3 loop geometry in TCR-pMHC recognition2026-07-04
- New NIH award: Assessment of Immune Responses to Neoantigen Vaccination in Lynch Syndrome2026-07-01
- New paper: Unbiased avidity-based isolation of antigen-specific T cells (Journal for ImmunoTherapy of Cancer)2026-07-01
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-09-03
Data may not be current
Find elsewhere
ORCID: 0000-0003-4510-0382